NCT05051722 2026-04-17
ECHO
Mayo Clinic
Recruiting
Clinical Trials
27 trialsNCT07349641 2026-04-13
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
NCT07107334 2026-04-09
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
University of Florida
Phase 2 Recruiting
NCT07462663 2026-04-09
SHAPE-ENDO
Hospital Universitari de Bellvitge
Not yet recruiting
NCT07377734 2026-03-30
2026ColECFerSp
Peking University People's Hospital
Phase 2 Recruiting
NCT07436793 2026-02-27
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
New Mexico Cancer Research Alliance
Phase 2 Not yet recruiting
NCT02397083 2026-02-13
LEVER
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06464107 2026-02-09
Endometrial Cell Collection With the PadKit
Hackensack Meridian Health
Phase NA Recruiting
NCT04576104 2026-01-21
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer
Northwestern University
Phase 2 Active not recruiting
NCT05903131 2026-01-20
Uterine Preservation Via Lifestyle Transformation
Washington University School of Medicine
Phase 2 Recruiting
NCT07078838 2026-01-16
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT03671811 2026-01-06
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
City of Hope Medical Center
Phase 2 Active not recruiting
NCT07298707 2025-12-23
EndoMethy-V
Peking Union Medical College Hospital
Not yet recruiting
NCT07145827 2025-09-12
Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen
Uruk University
Phase NA Completed
NCT03300557 2025-08-29
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT07137299 2025-08-22
POP-LAP
Medical University of Silesia
Not yet recruiting
NCT00788671 2025-08-15
Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05316935 2025-08-11
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
Fudan University
Phase 2/3 Recruiting
NCT06379113 2025-08-11
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
Fudan University
Phase 2/3 Recruiting
NCT04839614 2025-08-07
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT05463796 2025-08-07
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Dana-Farber Cancer Institute
Recruiting
NCT07077876 2025-07-22
CHOICE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT07048327 2025-07-02
TJ Intrauterin
Tongji Hospital
Recruiting
NCT07028242 2025-06-19
ULTRA-SAFE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT05647109 2025-05-04
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
Peking University People's Hospital
Recruiting
NCT06102863 2025-04-29
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Peking University People's Hospital
Phase 2 Recruiting
NCT05763667 2025-04-24
Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer
Tufts Medical Center
Phase 3 Completed